PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.45%
Growth of 5.45% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
6.69%
Cost growth of 6.69% versus flat Healthcare costs. Walter Schloss would verify cost control.
2.54%
Gross profit growth 1.25-1.5x Healthcare median of 1.94%. Mohnish Pabrai would examine sustainability.
-2.77%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-42.86%
R&D reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
4.21%
G&A change of 4.21% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
-30.50%
Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
43.24%
Other expenses change of 43.24% versus flat Healthcare costs. Walter Schloss would verify efficiency.
7.44%
Operating expenses change of 7.44% versus flat Healthcare costs. Walter Schloss would verify control.
7.00%
Total costs change of 7.00% versus flat Healthcare costs. Walter Schloss would verify control.
-21.09%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
7.03%
D&A change of 7.03% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
-625.01%
EBITDA decline while Healthcare median is 0.02%. Seth Klarman would investigate causes.
-597.86%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-15.44%
Operating income decline while Healthcare median is 5.19%. Seth Klarman would investigate causes.
-9.48%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1562.95%
Other expenses reduction while Healthcare median is -4.31%. Seth Klarman would investigate advantages.
-146.52%
Pre-tax income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-133.77%
Pre-tax margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
129.80%
Tax expense change of 129.80% versus flat Healthcare. Walter Schloss would verify strategy.
-117.73%
Net income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-106.48%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-120.58%
EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-123.71%
Diluted EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1.20%
Share count reduction while Healthcare median is 0.40%. Seth Klarman would investigate strategy.
-1.20%
Diluted share reduction while Healthcare median is 0.31%. Seth Klarman would investigate strategy.